{"id":11367,"date":"2020-04-01T18:49:52","date_gmt":"2020-04-01T13:19:52","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=11367"},"modified":"2025-06-23T10:42:00","modified_gmt":"2025-06-23T05:12:00","slug":"virtual-clinical-trial","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/","title":{"rendered":"NHS Advises COVID-19 Related Risk Assessment of Phase I Trials"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">In a recently released <a aria-label=\"statement (opens in a new tab)\" href=\"https:\/\/www.gov.uk\/government\/news\/status-of-phase-1-clinical-trials-in-response-to-coronavirus-covid-19\" target=\"_blank\" rel=\"noreferrer noopener\">statement<\/a>, the NHS has advised all companies that are conducting early phase clinical trials to seek confirmation that the trials have undergone a risk assessment in relation to coronavirus (COVID-19). As per the statement, this is likely to result in the halt\/termination of some of the virtual clinical trial. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With several governments announcing social distancing and other measures to reduce the spread of COVID-19, a surge in more news associated with trial termination is expected.  In fact, A number of pharmaceutical companies have&nbsp;<a href=\"https:\/\/www.statnews.com\/2020\/03\/23\/as-covid-19-spreads-disruptions-to-clinical-trial-and-drug-development-accelerate\/\">halted clinic studies<\/a>&nbsp;in recent days.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"545\" height=\"318\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/COVID-19-Related-Risk-Assessment-Screenshot-of-Twitter-link-Roots-1.webp\" alt=\"Snapshot on views of stakeholders\" class=\"wp-image-18962\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/COVID-19-Related-Risk-Assessment-Screenshot-of-Twitter-link-Roots-1.webp 545w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/COVID-19-Related-Risk-Assessment-Screenshot-of-Twitter-link-Roots-1-300x175.webp 300w\" sizes=\"auto, (max-width: 545px) 100vw, 545px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">An interesting article, published two days ago in&nbsp;<em>Nature<\/em>&nbsp;titled,&nbsp;<em><strong><a href=\"https:\/\/www.nature.com\/articles\/d41586-020-00889-6\">Cancer drug trials on hold amid coronavirus disruption<\/a><\/strong><\/em>, presented a patient\u2019s view on the impact of halted clinical trials due to COVID-19.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In order to minimize the impact of the COVID-19 on clinical trials, the US FDA has also urged pharmaceutical companies to switch to virtual clinical trials. In a recently published <a href=\"https:\/\/www.rootsanalysis.com\/blog\/clinical-trials-during-covid-19-time-to-go-virtual\/\">article<\/a>, we discussed, in detail, the key insights associated with virtual clinical trials.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Big Pharma and Virtual Clinical Trial<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Virtual clinical trial already appear to have decent adoption across the pharma companies. Roots Analysis conducted an analysis of the top pharmaceutical companies. The detailed analysis included those players that have sponsored\/plan to sponsor a virtual clinical study; these include Pfizer, Johnson and Johnson, Sanofi, Novartis, GlaxoSmithKline, and Amgen. The figure below highlights some of these initiatives:<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pfizer: A Pioneer in Virtual Clinical Trial<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In 2011, Pfizer pioneered the first-ever virtual trial, known as the Research on <a rel=\"noreferrer noopener\" aria-label=\"Electronic Monitoring of Overactive bladder Treatment Experience (REMOTE) (opens in a new tab)\" href=\"http:\/\/www.appliedclinicaltrialsonline.com\/pfizers-remote-virtual-experience\" target=\"_blank\">Electronic Monitoring of Overactive bladder Treatment Experience (REMOTE)<\/a> trial. It was a randomized clinical trial, which was conducted using mobile phones and web-based tools. This allowed the patients to participate in the trial regardless of their proximity to clinical sites. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, the trial observed significant patient drop-out. In fact, only 18 individuals finally received the treatment. In spite of this, the results of the study were consistent with those of a conventional study. Trial investigators conjectured that the trial failed to recruit patients because of the complex online registration process. Nevertheless, the trial paved the way for other companies to explore the possibilities of virtual clinical trials.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With time, a number of pharmaceutical companies have adopted virtual clinical trials. Amid the ongoing COVID-19 crisis, there is a rising demand for companies that can carry out clinical trials virtually. To know more about virtual clinical trials, potential partners, or general market insights, drop a note at rohit.kumar@rootsanalysis.com. Also, check out our report page to know more about the novel clinical trial designs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a recently released statement, the NHS has advised all companies that are conducting early phase clinical trials to seek confirmation that the trials have undergone a risk assessment in relation to coronavirus (COVID-19). As per the statement, this is likely to result in the halt\/termination of some of the virtual clinical trial. With several [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":11321,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[122],"tags":[200,374,373],"class_list":["post-11367","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-trials","tag-coronavirus","tag-covid-19","tag-virtual-clinical-trial"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Virtual Clinical Trial: NHS Advises Risk Assessment of Phase I<\/title>\n<meta name=\"description\" content=\"Virtual clinical trial already appear to have decent adoption across the pharma companies includes Pfizer, Johnson and Johnson, Sanofi\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Virtual Clinical Trial: NHS Advises Risk Assessment of Phase I\" \/>\n<meta property=\"og:description\" content=\"Virtual clinical trial already appear to have decent adoption across the pharma companies includes Pfizer, Johnson and Johnson, Sanofi\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-01T13:19:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-23T05:12:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/03\/image-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"544\" \/>\n\t<meta property=\"og:image:height\" content=\"278\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gaurav Chaudhary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gaurav Chaudhary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/\"},\"author\":{\"name\":\"Gaurav Chaudhary\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/e8e0ebc31296140424e1e7fcc11331bc\"},\"headline\":\"NHS Advises COVID-19 Related Risk Assessment of Phase I Trials\",\"datePublished\":\"2020-04-01T13:19:52+00:00\",\"dateModified\":\"2025-06-23T05:12:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/\"},\"wordCount\":441,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/image-3.png\",\"keywords\":[\"Coronavirus\",\"COVID-19\",\"Virtual Clinical Trial\"],\"articleSection\":[\"Clinical Trials\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/\",\"name\":\"Virtual Clinical Trial: NHS Advises Risk Assessment of Phase I\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/image-3.png\",\"datePublished\":\"2020-04-01T13:19:52+00:00\",\"dateModified\":\"2025-06-23T05:12:00+00:00\",\"description\":\"Virtual clinical trial already appear to have decent adoption across the pharma companies includes Pfizer, Johnson and Johnson, Sanofi\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/image-3.png\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/image-3.png\",\"width\":544,\"height\":278,\"caption\":\"Virtual Clinical Trials\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/virtual-clinical-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NHS Advises COVID-19 Related Risk Assessment of Phase I Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/e8e0ebc31296140424e1e7fcc11331bc\",\"name\":\"Gaurav Chaudhary\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g\",\"caption\":\"Gaurav Chaudhary\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Virtual Clinical Trial: NHS Advises Risk Assessment of Phase I","description":"Virtual clinical trial already appear to have decent adoption across the pharma companies includes Pfizer, Johnson and Johnson, Sanofi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/","og_locale":"en_US","og_type":"article","og_title":"Virtual Clinical Trial: NHS Advises Risk Assessment of Phase I","og_description":"Virtual clinical trial already appear to have decent adoption across the pharma companies includes Pfizer, Johnson and Johnson, Sanofi","og_url":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2020-04-01T13:19:52+00:00","article_modified_time":"2025-06-23T05:12:00+00:00","og_image":[{"width":544,"height":278,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/03\/image-3.png","type":"image\/png"}],"author":"Gaurav Chaudhary","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Gaurav Chaudhary","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/"},"author":{"name":"Gaurav Chaudhary","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/e8e0ebc31296140424e1e7fcc11331bc"},"headline":"NHS Advises COVID-19 Related Risk Assessment of Phase I Trials","datePublished":"2020-04-01T13:19:52+00:00","dateModified":"2025-06-23T05:12:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/"},"wordCount":441,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/03\/image-3.png","keywords":["Coronavirus","COVID-19","Virtual Clinical Trial"],"articleSection":["Clinical Trials"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/","url":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/","name":"Virtual Clinical Trial: NHS Advises Risk Assessment of Phase I","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/03\/image-3.png","datePublished":"2020-04-01T13:19:52+00:00","dateModified":"2025-06-23T05:12:00+00:00","description":"Virtual clinical trial already appear to have decent adoption across the pharma companies includes Pfizer, Johnson and Johnson, Sanofi","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/03\/image-3.png","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2020\/03\/image-3.png","width":544,"height":278,"caption":"Virtual Clinical Trials"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/virtual-clinical-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"NHS Advises COVID-19 Related Risk Assessment of Phase I Trials"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/e8e0ebc31296140424e1e7fcc11331bc","name":"Gaurav Chaudhary","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1661cbb4c9924618db626ec780a3daf2ebd251e93753c083102682dba715ded6?s=96&d=mm&r=g","caption":"Gaurav Chaudhary"}}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/11367","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=11367"}],"version-history":[{"count":5,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/11367\/revisions"}],"predecessor-version":[{"id":22194,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/11367\/revisions\/22194"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/11321"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=11367"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=11367"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=11367"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}